Nearly 300,000 children are born with sickle cell disease (SCD) around the world each year. Watch Michael R. Debaun, MD, MPH, discuss how the Primary Prevention of Stroke in Children with SCD in Sub-Saharan Africa II study, funded by the National Institute of Neurological Disorders and Stroke, aims to help children with sickle cell disease live stroke-free by 2025. This video is by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Dr. Debaun is a professor of pediatrics and medicine at Vanderbilt University School of Medicine and the Director of the Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease. Learn more: http://www.nhlbi.nih.gov Follow us on Twitter: http://www.twitter.com/nih_nhlbi Like us on Facebook: http://www.facebook.com/NHLBI
National Heart, Lung, and Blood Institute
National Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.
Core Mission Areas
The Science
Discover the goals, challenges, and initiatives that have shaped and will continue to shape prevention, diagnosis, and treatment for the NHLBI’s scientific focus areas.
Clinical Trials
NHLBI-funded clinical trials look at new ways to prevent, detect, or treat disease. The NHLBI is also focused on management and oversight of these trials.
Grants and Training
The NHLBI is committed to helping researchers establish independent careers. Locate the latest research and career development funding opportunities
Get In Touch
National Heart, Lung, and Blood Institute
Building 31
31 Center Drive
Bethesda, MD 20892
1-877-NHLBI4U (1-877-645-2448)
- Log in to post comments
- 42 views
- 38 views